Foghorn Therapeutics to Host Research & Development Day Webinar on June 15th

NEXT STORY
Kiniksa Outlines Next Steps for the Development of Mavrilimumab
PREV STORY
PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study in Oral Presentation at ASCO 2021 Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Summit Academy Embraces Science of RxAir UV Light Air Purifiers to Reduce COVID-19 Risk

author_avatar
NASDAQ Market News

Medivir announces that development of the HCV nucleotide polymerase inhibitor AL-704 was terminated by Janssen

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the development of ...

author_avatar
NASDAQ Market News

Medical Electronics Market to reach US $7,564.14 million by 2028 – Global Insights on Trends, Key Stakeholders, Competitive Landscape, Growth Drivers and Future Prospect: Adroit Market Research

author_avatar
NASDAQ Market News